Patents by Inventor Mike HELMS

Mike HELMS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RNA COMPOSITIONS AND METHODS FOR INHIBITING LIPOPROTEIN(A)
    Publication number: 20240035029
    Abstract: The present disclosure relates to dsRNAs targeting LPA mRNA and modulating Lp(a) plasma levels, and methods of treating one or more conditions associated with LPA gene expression.
    Type: Application
    Filed: October 15, 2021
    Publication date: February 1, 2024
    Inventors: Bodo BRUNNER, Bertrand FROTTIER, Etienne GUILLOT, Mike HELMS, Armin HOFMEISTER, Kerstin JAHN-HOFMANN, Sabine SCHEIDLER
  • NOVEL RNA COMPOSITIONS AND METHODS FOR INHIBITING ANGPTL3
    Publication number: 20230383294
    Abstract: The present disclosure relates to dsRNAs targeting ANGPTL3, methods of inhibiting ANGPTL3 gene expression, and methods of treating one or more conditions associated with ANGPTL3 gene expression.
    Type: Application
    Filed: October 15, 2021
    Publication date: November 30, 2023
    Inventors: Bodo BRUNNER, Mike HELMS, Armin HOFMEISTER, Kerstin JAHN-HOFMANN, Christiane METZ-WEIDMANN, Sabine SCHEIDLER, Pierrick RIVAL
  • NOVEL RNA COMPOSITIONS AND METHODS FOR INHIBITING ANGPTL8
    Publication number: 20220025367
    Abstract: The present disclosure relates to dsRNAs targeting ANGPTL8, methods of inhibiting ANGPTL8 gene expression, and methods of treating one or more conditions associated with ANGPTL8 gene expression.
    Type: Application
    Filed: November 22, 2019
    Publication date: January 27, 2022
    Applicant: Sanofi
    Inventors: Bodo BRUNNER, Mike HELMS, Armin HOFMEISTER, Kerstin JAHN-HOFMANN, Christiane METZ-WEIDMANN, Sabine SCHEIDLER, Pierrick RIVAL